packageAbrocitinib

abrocitinib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Abrocitinib is a protein kinase inhibitor used to treat atopic dermatitis. It is authorised in the European Union as a dermatological medicine for dermatitis and is in approved use.

Summary written by glm-5.3-flash from Wikidata Q76656815 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:abrocitinib
ATC codes:D11AH08
DrugBank:DB14973
PubChem CID:78323835
Wikidata:Q76656815
formula:C14H21N5O2S
molar mass:323.415 g/mol (PubChem CID 78323835)
logP:1.7 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown